Emphasizing the significance of an AD-specific neuroprotective peptide HN in mitigating AD-related neurotoxicity by activating the JAK2/STAT3 signaling axis, these researchers observed that the age- and disease-dependent decline in the JAK2/STAT3 axis plays a pivotal role in the pathogenesis of AD. This evidence concerns the gene JAK2 and Alzheimer disease.